Prospero Biosciences has developed an ion detector that effectively increases the characterization and identification capabilities that is 30 times better than what is currently available. With our patented detection system, our researchers can extend the dynamic range limits with unmatched resolution and sensitivity in the field of mass spectrometry. Our detection system will assist scientists and clinicians make advancements for applications in virus detection, proteomics, pharmaceuticals, and diagnostics.
We provide a high mass molecule detector for the mass spectrometry market, more specifically for the MALDI-TOF and Q-TOF segment. The technology provides 15 times better resolution compared to the competitor, which is crucial for accurate identification. The company is currently developing a universal detector.
Company Details
- Employees
- 1
- Founded
- -
- Industry
- Nanotechnology Research
- NAICS
-
Research and Development in Nanotechnology
- Website
- prosperobiosciences.com
Prospero Biosciences Questions
Prospero Biosciences's website is prosperobiosciences.com
Prospero Biosciences's LinkedIn profile is https://www.linkedin.com/company/prospero-biosciences
Prospero Biosciences has
1 employees.
View email and phone details for 1
employees at Prospero Biosciences.
Prospero Biosciences's industry is
Nanotechnology Research
Prospero Biosciences's top competitors are
Pacira Germany,
Breakpoint Therapeutics,
Lurmetrika,
Altona Diagnostics,
Weroi,
Aqvida Gmbh,
Xiogenix,
Osatek, S.a.,
Hawk Biosystems,
Lignopure.
Prospero Biosciences's categories are Nanotechnology Research
Prospero Biosciences's founding year is 2012
